These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8399593)

  • 1. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections.
    Herwaldt LA
    Perit Dial Int; 1993; 13 Suppl 2():S301-5. PubMed ID: 8399593
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis.
    Araki Y; Hataya H; Ikeda M; Ishikura K; Honda M
    Perit Dial Int; 2003; 23(3):267-9. PubMed ID: 12938828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus CAPD-related infections are associated with nasal carriage.
    Lye WC; Leong SO; van der Straaten J; Lee EJ
    Adv Perit Dial; 1994; 10():163-5. PubMed ID: 7999818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal carriage of Staph. aureus in peritonitis and exit-site infections.
    De Vecchi AF; Morelli JM; Mascheroni E; Parolari R; Capaccio P; Scaramellini G
    Perit Dial Int; 1997; 17(2):205-7. PubMed ID: 9159847
    [No Abstract]   [Full Text] [Related]  

  • 5. Staphylococcus aureus nasal carriage is not associated with an increased incidence of exit-site infection with the same organism.
    Twardowski ZJ; Prowant BF
    Perit Dial Int; 1993; 13 Suppl 2():S306-9. PubMed ID: 8399594
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results.
    Pérez-Fontán M; García-Falcón T; Rosales M; Rodríguez-Carmona A; Adeva M; Rodríguez-Lozano I; Moncalián J
    Am J Kidney Dis; 1993 Nov; 22(5):708-12. PubMed ID: 8238017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
    Al-Hwiesh AK; Abdul Rahman IS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis].
    Boelaert JR; Van Landuyt HW; De Baere YA; Gheyle DW; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
    Nephrologie; 1994; 15(2):157-61. PubMed ID: 8047204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of peritonitis.
    Piraino B
    Perit Dial Int; 1998; 18(3):244-6. PubMed ID: 9663885
    [No Abstract]   [Full Text] [Related]  

  • 10. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Pignatari A; Pfaller M; Hollis R; Sesso R; Leme I; Herwaldt L
    J Clin Microbiol; 1990 Sep; 28(9):1898-902. PubMed ID: 2172293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis.
    Ndlovu KCZ; Swe Swe-Han K; Assounga A
    Ren Fail; 2019 Nov; 41(1):303-313. PubMed ID: 30991864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
    Ritzau J; Hoffman RM; Tzamaloukas AH
    Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.
    Herwaldt LA
    J Hosp Infect; 1998 Sep; 40 Suppl B():S13-23. PubMed ID: 9777529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
    Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
    Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
    Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F
    N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
    Piraino B; Perlmutter JA; Holley JL; Bernardini J
    Perit Dial Int; 1993; 13 Suppl 2():S332-4. PubMed ID: 8399602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of catheter related infections in patients on CAPD.
    Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.